ACP-5862

Modify Date: 2024-01-02 21:32:44

ACP-5862 Structure
ACP-5862 structure
Common Name ACP-5862
CAS Number 2230757-47-6 Molecular Weight 481.51
Density N/A Boiling Point N/A
Molecular Formula C26H23N7O3 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of ACP-5862


ACP-5862 is a major active, circulating, pyrrolidine ring-opened metabolite of Acalabrutinib with an IC50 of 5.0 nM for Bruton tyrosine kinase (BTK)[1]. Acalabrutinib is an orally active, irreversible, and highly selective BTK inhibitor, with an IC50 of 3 nM and EC50 of 8 nM[2].

 Names

Name ACP-5862

 ACP-5862 Biological Activity

Description ACP-5862 is a major active, circulating, pyrrolidine ring-opened metabolite of Acalabrutinib with an IC50 of 5.0 nM for Bruton tyrosine kinase (BTK)[1]. Acalabrutinib is an orally active, irreversible, and highly selective BTK inhibitor, with an IC50 of 3 nM and EC50 of 8 nM[2].
Related Catalog
Target

IC50: 5.0 nM (BTK)[1]

References

[1]. Podoll T, et al. Bioavailability, Biotransformation, and Excretion of the Covalent Bruton Tyrosine Kinase Inhibitor Acalabrutinib in Rats, Dogs, and Humans. Drug Metab Dispos. 2019 Feb;47(2):145-154.

[2]. Herman SE, et al. The Bruton's tyrosine kinase (BTK) inhibitor acalabrutinib demonstrates potent on-target effects and efficacy in two mouse models of chronic lymphocytic leukemia. Clin Cancer Res. 2016 Nov 30

 Chemical & Physical Properties

Molecular Formula C26H23N7O3
Molecular Weight 481.51